Scott Saunders

Title: Scott Saunders: Innovator in Synthetic Constructs

Introduction

Scott Saunders is a notable inventor based in Creve Coeur, MO (US). He has made significant contributions to the field of synthetic constructs, particularly in the area of proteoglycans. With a total of 4 patents to his name, his work has implications in various biological and medical applications.

Latest Patents

Among his latest patents is the construction and use of synthetic constructs encoding syndecan. This invention involves a purified mammalian proteoglycan and genetic information encoding such proteoglycans. The constructs have a core polypeptide molecular weight of about 30 kD to about 35 kD. They comprise a hydrophilic amino terminal extracellular region, a hydrophilic carboxy terminal cytoplasmic region, and a transmembrane hydrophobic region. Additionally, the constructs include a protease-susceptible cleavage sequence and at least one glycosylation site for the attachment of a heparan sulfate chain. The glycosylation site is represented by a specific formula, which allows for variations based on this site.

Career Highlights

Scott has worked with reputable organizations such as Children's Medical Center Corporation and Leland Stanford Junior University. His experience in these institutions has contributed to his expertise in the field of synthetic constructs and proteoglycans.

Collaborations

Some of his notable coworkers include Merton Bernfield and Masato Kato. Their collaboration has likely enriched the research and development of synthetic constructs in which Scott has been involved.

Conclusion

Scott Saunders is a distinguished inventor whose work in synthetic constructs has advanced the understanding of proteoglycans. His contributions through patents and collaborations continue to influence the field significantly.